• Info
  • Insider Ownership

Insider Trading & Ownership of Helen Torley

Location
San Diego, CA
Summary
The estimated net worth of Helen Torley is at least $56,279,151 dollars as of 07 Apr 2026. Helen Torley is the PRESIDENT AND CEO, Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $55.51M. Helen Torley is the Director of QUEST DIAGNOSTICS INC and owns shares of QUEST DIAGNOSTICS INC (DGX) stock worth about $769.1K.
Signature
/s/ James R. Oehler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Helen Torley and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Helen Torley has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $56,279,151.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: HALOZYME THERAPEUTICS, INC. ($55,510,029).
  • Past-year value change for that position: -$35,013,290.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Helen Torley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HALO HALOZYME THERAPEUTICS, INC. PRESIDENT AND CEO, Director $55,510,029 -$35,013,290 -39% 06 Apr 2026
DGX QUEST DIAGNOSTICS INC Director $769,122 25 May 2021

Insider Transactions Reported by Helen Torley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.